American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: Role of EGFR

BMC Complementary and Alternative Medicine

Volumn 11, Issue , 2011, Pages

  Dougherty, Urszula ^a   Mustafi, Reba ^a   Wang, Yunwei ^a   Musch, Mark W ^a   Wang, Chong Zhi ^b   Konda, Vani J ^a   Kulkarni, Anirudh ^a   Hart, John ^a   Dawson, Glyn ^a   Kim, Karen E ^a   Yuan, Chun Su ^b   Chang, Eugene B ^a   Bissonnette, Marc ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 O BETA DEXTRO GLUCOPYRANOSYL 20 PROTOPANAXADIOL; ANTINEOPLASTIC AGENT; AZOXYMETHANE; CYCLOOXYGENASE 2; DEXTRAN SULFATE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GINSENG EXTRACT; KI 67 ANTIGEN; METRONIDAZOLE; RNA 16S; UNCLASSIFIED DRUG; EGFR PROTEIN, MOUSE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; COLITIS; COLON CANCER; CONTROLLED STUDY; DIETARY INTAKE; GINSENG; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MICROBIAL DIVERSITY; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; ANIMAL; BACTERIUM; CELL TRANSFORMATION; CHEMISTRY; COLON; COLON TUMOR; DISEASE MODEL; DOWN REGULATION; DRUG EFFECT; FAT INTAKE; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PANAX; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BACTERIA; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLONIC NEOPLASMS; DIETARY FATS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HUMANS; MALE; MICE; PANAX; PLANT EXTRACTS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 80655139140     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-11-111     Document Type: Article

References (61)

1. Yang K, Kurihara N, Fan K, Newmark H, Rigas B, Bancroft L, Corner G, Livote E, Lesser M, Edelmann W, et al. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. Cancer Res 2008, 68:7803-7810. 10.1158/0008-5472.CAN-08-1209, 18829535.
2. Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 2009, 30:88-92. 2722141, 19017685.
3. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res 1997, 57:253-258.
4. Dougherty U, Cerasi D, Taylor I, Kocherginsky M, Tekin U, Badal S, Aluri L, Sehdev A, Cerda S, Mustafi R, et al. Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-alpha and PTGS2. Clin Cancer Res 2009, 15:6780-6789. 10.1158/1078-0432.CCR-09-1678, 2785126, 19903783.
5. Zhu H, Dougherty U, Robinson V, Mustafi R, Pekow J, Kupfer S, Li YC, Hart J, Goss K, Fichera A, et al. EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res 2011, 9:960-975. 10.1158/1541-7786.MCR-10-0531, 21653642.
6. Yun TK, Choi SY. Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev 1995, 4:401-408.
7. Yun TK, Zheng S, Choi SY, Cai SR, Lee YS, Liu XY, Cho KJ, Park KY. Non-organ-specific preventive effect of long-term administration of Korean red ginseng extract on incidence of human cancers. J Med Food 2010, 13:489-494. 10.1089/jmf.2009.1275, 20521975.
8. Yun TK, Choi SY. Non-organ specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol 1998, 27:359-364. 10.1093/ije/27.3.359, 9698120.
9. Yun TK. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 2003, 523-524:63-74.
10. Qi LW, Wang CZ, Yuan CS. American ginseng: potential structure-function relationship in cancer chemoprevention. Biochem Pharmacol 2010, 80:947-954. 10.1016/j.bcp.2010.06.023, 20599804.
11. Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 2001, 16(Suppl):S28-37. 3202208, 11748374.
12. Wang CZ, Li XL, Wang QF, Mehendale SR, Fishbein AB, Han AH, Sun S, Yuan CS. The mitochondrial pathway is involved in American ginseng-induced apoptosis of SW-480 colon cancer cells. Oncol Rep 2009, 21:577-584. 2676877, 19212614.
13. Luo X, Wang CZ, Chen J, Song WX, Luo J, Tang N, He BC, Kang Q, Wang Y, Du W, et al. Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. Int J Oncol 2008, 32:975-983. 2677725, 18425323.
14. Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, He TC, Yuan CS. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med 2007, 73:669-674. 10.1055/s-2007-981524, 2657361, 17538869.
15. Xie JT, Wang CZ, Zhang B, Mehendale SR, Li XL, Sun S, Han AH, Du W, He TC, Yuan CS. In vitro and in vivo anticancer effects of American ginseng berry: exploring representative compounds. Biol Pharm Bull 2009, 32:1552-1558. 10.1248/bpb.32.1552, 19721231.
16. Keum YS, Park KK, Lee JM, Chun KS, Park JH, Lee SK, Kwon H, Surh YJ. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett 2000, 150:41-48. 10.1016/S0304-3835(99)00369-9, 10755385.
17. Surh YJ, Na HK, Lee JY, Keum YS. Molecular mechanisms underlying anti-tumor promoting activities of heat-processed Panax ginseng C.A. Meyer. J Korean Med Sci 2001, 16(Suppl):S38-41. 3202206, 11748375.
18. Han HJ, Yoon BC, Lee SH, Park SH, Park JY, Oh YJ, Lee YJ. Ginsenosides inhibit EGF-induced proliferation of renal proximal tubule cells via decrease of c-fos and c-jun gene expression in vitro. Planta Med 2002, 68:971-974. 10.1055/s-2002-35659, 12451485.
19. Cui X, Jin Y, Poudyal D, Chumanevich AA, Davis T, Windust A, Hofseth A, Wu W, Habiger J, Pena E, et al. Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis. Carcinogenesis 2010, 31:1734-1741. 10.1093/carcin/bgq163, 2950936, 20729391.
20. Fiala ES. Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane. Cancer 1977, 40:2436-2445. 10.1002/1097-0142(197711)40:5+<2436::AID-CNCR2820400908>3.0.CO;2-U, 200341.
21. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004, 95:475-480. 10.1111/j.1349-7006.2004.tb03235.x, 15182426.
22. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003, 94:965-973. 10.1111/j.1349-7006.2003.tb01386.x, 14611673.
23. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 1996, 62:453-457. 10.1055/s-2006-957938, 8923812.
24. Lee BH, Lee SJ, Hur JH, Lee S, Sung JH, Huh JD, Moon CK. In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria. Planta Med 1998, 64:500-503. 10.1055/s-2006-957501, 9741293.
25. Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Archives of pharmacal research 2004, 27:61-67. 10.1007/BF02980048, 14969341.
26. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. Journal of pharmacological sciences 2004, 95:153-157. 10.1254/jphs.FMJ04001X4, 15215638.
27. Song G, Guo S, Wang W, Hu C, Mao Y, Zhang B, Zhang H, Hu T. Intestinal metabolite compound K of ginseng saponin potently attenuates metastatic growth of hepatocellular carcinoma by augmenting apoptosis via a Bid-mediated mitochondrial pathway. J Agric Food Chem 2010, 58:12753-12760. 10.1021/jf103814f, 21121651.
28. Lee IK, Kang KA, Lim CM, Kim KC, Kim HS, Kim DH, Kim BJ, Chang WY, Choi JH, Hyun JW. Compound K, a metabolite of ginseng saponin, induces mitochondria-dependent and caspase-dependent apoptosis via the generation of reactive oxygen species in human colon cancer cells. Int J Mol Sci 2010, 11:4916-4931. 10.3390/ijms11124916, 3100836, 21614182.
29. Cho SH, Chung KS, Choi JH, Kim DH, Lee KT. Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells. BMC Cancer 2009, 9:449. 10.1186/1471-2407-9-449, 2806409, 20017956.
30. Park D, Bae DK, Jeon JH, Lee J, Oh N, Yang G, Yang YH, Kim TK, Song J, Lee SH, et al. Immunopotentiation and antitumor effects of a ginsenoside Rg(3)-fortified red ginseng preparation in mice bearing H460 lung cancer cells. Environ Toxicol Pharmacol 2011, 31:397-405. 10.1016/j.etap.2011.01.008, 21787710.
31. He BC, Gao JL, Luo X, Luo J, Shen J, Wang L, Zhou Q, Wang YT, Luu HH, Haydon RC, et al. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ss-catenin signaling. Int J Oncol 2011, 38:437-445.
32. Yoo JH, Kwon HC, Kim YJ, Park JH, Yang HO. KG-135, enriched with selected ginsenosides, inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athymic mice. Cancer Lett 2010, 289:99-110. 10.1016/j.canlet.2009.08.008, 19765891.
33. Wang W, Rayburn ER, Hao M, Zhao Y, Hill DL, Zhang R, Wang H. Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides. Prostate 2008, 68:809-819. 10.1002/pros.20742, 18324646.
34. Popov AM, Atopkina LN, Uvarova NI, Elyakov GB. The antimetastatic and immunomodulating activities of ginseng minor glycosides. Dokl Biochem Biophys 2001, 380:309-312. 10.1023/A:1012327806554, 11727551.
35. Dougherty U, Cerasi D, Taylor I, Kocherginsky M, Tekin U, Badal S, Aluri L, Sehdev A, Cerda S, Mustafi R, et al. Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-α and PTGS2. Clin Cancer Res 2009, 15:6780-6789. 10.1158/1078-0432.CCR-09-1678, 2785126, 19903783.
36. Wang CZ, Wu JA, McEntee E, Yuan CS. Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography. J Agric Food Chem 2006, 54:2261-2266. 10.1021/jf052993w, 16536605.
37. Wang CZ, Ni M, Sun S, Li XL, He H, Mehendale SR, Yuan CS. Detection of adulteration of notoginseng root extract with other panax species by quantitative HPLC coupled with PCA. J Agric Food Chem 2009, 57:2363-2367. 10.1021/jf803320d, 2705280, 19256509.
38. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993, 69:238-249.
39. Nambiar PR, Girnun G, Lillo NA, Guda K, Whiteley HE, Rosenberg DW. Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. Int J Oncol 2003, 22:145-150.
40. Ruff SJ, Chen K, Cohen S. Peroxovanadate induces tyrosine phosphorylation of multiple signaling proteins in mouse liver and kidney. J Biol Chem 1997, 272:1263-1267. 10.1074/jbc.272.2.1263, 8995430.
41. Fitch KR, McGowan KA, van Raamsdonk CD, Fuchs H, Lee D, Puech A, Herault Y, Threadgill DW, Hrabe de Angelis M, Barsh GS. Genetics of dark skin in mice. Genes Dev 2003, 17:214-228. 10.1101/gad.1023703, 195979, 12533510.
42. Becker C, Fantini MC, Neurath MF. High resolution colonoscopy in live mice. Nat Protoc 2006, 1:2900-2904.
43. Wang Y, Devkota S, Musch MW, Jabri B, Nagler C, Antonopoulos DA, Chervonsky A, Chang EB. Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon. PLoS One 2010, 5:e13607. 10.1371/journal.pone.0013607, 2962643, 21042588.
44. Drinkwater NR, Klotz JH. Statistical methods for the analysis of tumor multiplicity data. Cancer Res 1981, 41:113-119.
45. Gartel AL, Serfas MS, Tyner AL. p21--negative regulator of the cell cycle. Proc Soc Exp Biol Med 1996, 213:138-149.
46. Mahyar-Roemer M, Roemer K. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 2001, 20:3387-3398. 10.1038/sj.onc.1204440, 11423989.
47. Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol 1998, 50:1155-1160.
48. Jin Y, Kotakadi VS, Ying L, Hofseth AB, Cui X, Wood PA, Windust A, Matesic LE, Pena EA, Chiuzan C, et al. American ginseng suppresses inflammation and DNA damage associated with mouse colitis. Carcinogenesis 2008, 29:2351-2359. 10.1093/carcin/bgn211, 2639244, 18802031.
49. Hofseth LJ, Wargovich MJ. Inflammation, cancer, and targets of ginseng. J Nutr 2007, 137:183S-185S.
50. Kohno H, Suzuki R, Sugie S, Tanaka T. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer 2005, 5:46. 10.1186/1471-2407-5-46, 1156872, 15892897.
51. King ML, Murphy LL. Role of cyclin inhibitor protein p21 in the inhibition of HCT116 human colon cancer cell proliferation by American ginseng (Panax quinquefolius) and its constituents. Phytomedicine 2010, 17:261-268. 10.1016/j.phymed.2009.06.008, 2821959, 19674880.
52. Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem Biophys Res Commun 1998, 246:725-730. 10.1006/bbrc.1998.8690, 9618279.
53. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tecle H, Barrett SD, Bridges A, Przybranowski S, et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 1999, 5:810-816. 10.1038/10533, 10395327.
54. Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005, 24:7455-7464. 10.1038/sj.onc.1209085, 16288292.
55. DuBois RN, Shao J, Tsujii M, Sheng H, Beauchamp RD. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 1996, 56:733-737.
56. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, Hsu D, Xu R, Harpaz N, Dannenberg AJ, et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007, 133:1869-1881. 10.1053/j.gastro.2007.09.008, 2180834, 18054559.
57. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000, 105:1589-1594. 10.1172/JCI9621, 300858, 10841517.
58. Nehls O, Hass HG, Okech T, Zenner S, Hsieh CJ, Sarbia M, Borchard F, Gruenagel HH, Gaco V, Porschen R, et al. Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery alone. Int J Colorectal Dis 2009, 24:655-663. 10.1007/s00384-009-0635-0, 19221769.
59. Joh EH, Lee IA, Jung IH, Kim DH. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation. Biochem Pharmacol 2011, 82:278-286. 10.1016/j.bcp.2011.05.003, 21600888.
60. Glauert HP, Bennink MR. Metabolism of 1,2-dimethylhydrazine by cultured rat colon epithelial cells. Nutr Cancer 1983, 5:78-86. 10.1080/01635588309513782, 6647041.
61. Vannucci L, Stepankova R, Kozakova H, Fiserova A, Rossmann P, Tlaskalova-Hogenova H. Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity. Int J Oncol 2008, 32:609-617.